PASCA, SAMANTHA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.061
AS - Asia 4.261
EU - Europa 2.419
SA - Sud America 1.321
AF - Africa 1.288
OC - Oceania 121
Continente sconosciuto - Info sul continente non disponibili 69
Totale 15.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.350
SG - Singapore 1.429
BR - Brasile 816
HK - Hong Kong 798
CN - Cina 410
VN - Vietnam 370
PL - Polonia 296
IT - Italia 243
FR - Francia 184
FI - Finlandia 167
RU - Federazione Russa 144
DE - Germania 123
AR - Argentina 109
GB - Regno Unito 91
AT - Austria 88
KR - Corea 67
EC - Ecuador 66
MX - Messico 61
UA - Ucraina 61
TR - Turchia 60
BJ - Benin 59
SE - Svezia 57
CO - Colombia 55
IQ - Iraq 55
ID - Indonesia 54
IE - Irlanda 53
ZA - Sudafrica 53
PY - Paraguay 51
IN - India 49
NL - Olanda 48
BA - Bosnia-Erzegovina 47
CL - Cile 47
CZ - Repubblica Ceca 46
AE - Emirati Arabi Uniti 45
JO - Giordania 45
TN - Tunisia 45
UY - Uruguay 44
BZ - Belize 43
ES - Italia 43
IR - Iran 43
JM - Giamaica 42
PR - Porto Rico 42
KH - Cambogia 41
LA - Repubblica Popolare Democratica del Laos 41
MD - Moldavia 41
AO - Angola 40
BF - Burkina Faso 40
BG - Bulgaria 40
GA - Gabon 40
SA - Arabia Saudita 40
AL - Albania 39
BY - Bielorussia 39
DO - Repubblica Dominicana 39
JP - Giappone 39
PE - Perù 39
SN - Senegal 39
TT - Trinidad e Tobago 39
UG - Uganda 39
GT - Guatemala 38
KZ - Kazakistan 38
ME - Montenegro 38
PH - Filippine 38
TJ - Tagikistan 38
CW - ???statistics.table.value.countryCode.CW??? 37
EG - Egitto 37
LV - Lettonia 37
NI - Nicaragua 37
BE - Belgio 36
IL - Israele 36
VE - Venezuela 36
KG - Kirghizistan 35
PA - Panama 35
SI - Slovenia 35
AM - Armenia 34
BS - Bahamas 34
GF - Guiana Francese 34
HR - Croazia 34
HT - Haiti 34
MA - Marocco 34
NP - Nepal 34
SO - Somalia 34
ZM - Zambia 34
DZ - Algeria 33
GR - Grecia 33
LC - Santa Lucia 33
MR - Mauritania 33
MU - Mauritius 33
TZ - Tanzania 33
AZ - Azerbaigian 32
BW - Botswana 32
CR - Costa Rica 32
CV - Capo Verde 32
EE - Estonia 32
XK - ???statistics.table.value.countryCode.XK??? 32
ZW - Zimbabwe 32
CU - Cuba 31
ML - Mali 31
MZ - Mozambico 31
PS - Palestinian Territory 31
BD - Bangladesh 30
Totale 14.067
Salva come PNG Salva come JPEG
Città #
Fairfield 797
Hong Kong 768
Singapore 705
Ashburn 448
Woodbridge 362
Santa Clara 360
Houston 283
Seattle 265
Bytom 262
Ann Arbor 259
Cambridge 229
Wilmington 198
Boardman 195
San Diego 178
Medford 165
Princeton 165
Roxbury 141
Chandler 120
Des Moines 120
Helsinki 116
Ho Chi Minh City 102
Beijing 87
Hanoi 79
Los Angeles 72
Guangzhou 69
São Paulo 68
Cotonou 58
Dong Ket 53
Shanghai 49
Vienna 49
Buffalo 46
Chicago 46
Amman 45
Nuremberg 44
Dublin 40
Phnom Penh 40
Dakar 39
Kampala 39
Seoul 39
Libreville 38
New York 38
Dushanbe 37
Managua 37
Montevideo 37
Hefei 36
Bishkek 34
Luanda 34
Panama City 34
Podgorica 34
Riga 34
Lusaka 32
Vientiane 32
Willemstad 32
Castries 31
Nassau 31
Baku 30
Harare 30
Nouakchott 30
Redondo Beach 30
Abidjan 29
Bamako 29
Kigali 28
Minsk 28
Ouagadougou 28
Praia 28
Yerevan 28
Havana 27
Lima 27
Noumea 27
Tallinn 27
Niamey 26
Sofia 26
Antananarivo 25
Dar es Salaam 25
Guatemala City 25
Guayaquil 25
Kingstown 25
Bridgetown 24
London 24
Maputo 24
Tashkent 24
Ulan Bator 24
Andorra la Vella 23
Nairobi 23
Padova 23
Quito 23
Rio de Janeiro 23
Baghdad 22
Cayenne 22
Kingston 22
San José 22
Accra 21
Belize City 21
Conakry 21
Gaborone 21
Kinshasa 21
Lagos 21
Papeete 21
Pristina 21
Chisinau 20
Totale 8.865
Salva come PNG Salva come JPEG
Nome #
Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism: A Review of the RIETE Registry 394
A woman hemophilia carrier with life-threatening esophageal varices and a severe hemophiliac male: A comparison of two different case reports and a brief description of literature 173
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study 168
Fondaparinux in the initial and long-term treatment of venous thromboembolism 165
Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation 159
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry 157
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 155
La patologia cerebro e cardiovascolare nel paziente emofilico adulto dall’epidemiologia al trattamento. Registro multicentrico, retrospettivo-prospettico. 151
Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs 151
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®) 151
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. 150
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 150
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 149
Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry 144
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism 143
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity 143
Factors Associated with elevated Pulmonary Arterial Pressure Levels on the Echocardiographic Assessment in Patients with Prior Pulmonary Embolism 142
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 140
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism 138
Unsuspected pulmonary embolism in patients with cancer 136
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study 135
Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry. 134
PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A 134
Clinical presentation and outcome of venous thromboembolism in COPD 133
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism 130
Activated prothrombin complex concentrate (FEIBA ® ) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry 129
Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism 125
Cerebrovascular diseases in hemophiliacs: A real, but underestimated risk 121
Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function 119
Usefulness of Thrombophilia Testing in Venous Thromboembolic Disease: Findings From the RIETE Registry 118
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer 116
The Italian START-Register on anticoagulation with focus on atrial fibrillation 116
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs 112
Clinical significance of a negative D-dimer level in patients with confirmed venous thromboembolism. Findings from the RIETE Registry 111
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report 111
Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry 111
Aspirin for preventing the recurrence of venous thromboembolism 110
Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism 109
Bleeding complications associated with anticoagulant therapy in patients with cancer 108
Prothrombin complex concentrate such as therapy and prophylaxis in factor X-deficient patient (Friuli Variant) 108
Can the plasmaderived factor VIII still play a role in the treatment of acquired hemophilia A at the time of new drugs? 108
Immunosuppression for acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) 107
16. The real-life use of rFXIII (catridecacog) in patients with severe Factor XIII deficiency: an Italian survey. 106
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study 106
Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis 105
Cancers in patients with hemophilia: A retrospective study from the Italian Association of Hemophilia Centers 105
Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres 105
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison 104
Platelet count and outcome in patients with acute venous thromboembolism 104
Use of recombinant activated factor VII in severe post-partum haemorrhage: Data from the Italian Registry. A multicentric observational retrospective study 103
Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient 103
Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population 102
An Italian Survey on the real-world use of rFXIII (catridecacog) in patients with factor XIII deficiency 102
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: A multicenter cohort study 102
Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism 101
Venous thromboembolism during pregnancy, postpartum or during contraceptive use: Findings from the RIETE Registry 101
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency 101
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry 100
Demographic and clinical data in acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) 99
Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? 99
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding 98
Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review 97
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry 95
Recurrent venous thromboembolism in anticoagulated patients with cancer: Management and short-term prognosis 95
Platelet count and major bleeding in patients receiving Vitamin K antagonists for acute venous thromboembolism, findings from real world clinical practice 95
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 94
Efficacy and safety of peripheral blood stem cell mobilization and collection: A single-center experience in 190 allogeneic donors 94
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs 94
Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry 93
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience 93
Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: Findings from the RIETE Registry 93
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency 93
Direct Oral Anticoagulants for Very Elderly People with Atrial Fibrillation: Efficacy and Safe Enough? 92
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres 91
Caesarean surgery or vaginal delivery in a pregnant woman with homozygous FXI deficiency and FXI level <1%? This is the question! 91
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 91
Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A 89
Thrombophilic mutations as risk factor for retinal vein occlusion: A case-control study 89
Major bleeding as a predictor of mortality in patients with venous thromboembolism: Findings from the RIETE Registry 89
Retinal vein occlusion: Evaluation of "classic" and "emerging" risk factors and treatment 88
Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review 88
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry 88
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism 87
Population pharmacokinetics of different clotting factor concentrates in fifty-six patients with severe hemophilia A: a single center experience 86
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE registry 86
Long-term outcomes of patients with cerebral vein thrombosis: A multicenter study 86
Pregnancy-associated acquired haemophilia A: Results from the European Acquired Haemophilia (EACH2) registry 85
Gender differences in cancer patients with acute venous thromboembolism 85
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study 85
The successful use of susoctocog-alfa (rpFVIII) in the treatment of nine elderly patients presenting acquired haemophilia A: a multicenter case series 85
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism 85
The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha 84
PdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease? 83
Management of bleeding in acquired hemophilia A: Results from the European Acquired Haemophilia (EACH2) registry 83
Vanishing bile duct syndrome in non-Hodgkin lymphoma: a case report 83
Extended Compression Ultrasound Performed by Emergency Physicians: A Modified Compression Ultrasound Examination to Detect Superficial and Deep Lower Limb Thromboses in the Emergency Department 82
Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy 81
Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: The history of a success 81
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: The SHAPE Study 81
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues 81
Totale 11.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.335
article - articoli 51.796
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021590 0 0 0 0 0 1 10 27 275 52 21 204
2021/20222.095 58 83 251 123 422 86 134 160 165 30 123 460
2022/2023646 283 12 7 18 70 75 10 37 73 10 32 19
2023/2024690 12 46 39 55 51 59 43 32 31 135 68 119
2024/20253.538 16 208 171 33 584 82 157 225 408 169 702 783
2025/20267.207 242 1.363 2.190 2.276 937 199 0 0 0 0 0 0
Totale 15.775